Why the study?
Does transcatheter aortic valve implantation (TAVI) improve biological parameters and prognosis at one month in patients with severe aortic stenosis?
Does transcatheter aortic valve implantation (TAVI) improve biological parameters and prognosis at one month in patients with severe aortic stenosis?
Answers are grounded in this paper and cite their sources.
TAVI improves the short-term prognosis and biological parameters of patients with severe aortic stenosis at one month.
Aortic stenosis is one of the most common valve diseases in patients over 60 years of age. Lack of prompt surgical correction by conventional valve replacement or interventional transcatheter aortic valve implantation (TAVI) increases the risk of morbidity and mortality, in the context of worsening clinical picture. Since the first interventional transcatheter valve implantation procedure in 2012 and to date, the evolution of technology and refinement of medical techniques has led to the refinement of the treatment method and thus to the improvement of the prognosis of patients with aortic stenosis undergoing TAVI after only one month.
No takes yet. Share an insight, caveat, or question.
Dumitrof et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: